The glyburide report card

Barak M. Rosenn

Research output: Contribution to journalShort surveypeer-review

6 Scopus citations


Over the past decade, several studies have been published describing the use of glyburide for the treatment of women with gestational diabetes (GDM). These studies include randomized prospective trials, prospective studies, and cohort studies. With a total of more than 1000 patients, they encompass a wide range of patient populations and treatment centers and demonstrate the effectiveness of oral treatment in achieving good glycemic control in women with GDM. Taken together, these studies have demonstrated that glyburide is as safe and as useful as insulin for the treament of women with GDM and will likely become universally accepted as the first line drug of choice for treatment of this condition.

Original languageEnglish
Pages (from-to)219-223
Number of pages5
JournalJournal of Maternal-Fetal and Neonatal Medicine
Issue number3
StatePublished - Mar 2010
Externally publishedYes


  • Gestational diabetes
  • Glyburide
  • Maternal glucose control
  • Review


Dive into the research topics of 'The glyburide report card'. Together they form a unique fingerprint.

Cite this